JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:JCR Pharmaceuticals Co Ltd (4552) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11531
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner syndrome, adult growth hormone deficiency, small for gestational age, renal anemia in dialysis patients and anemia of prematurity; and a regenerative medical product for acute graft-versus-host disease. JCR is also involved in the purchasing, selling, import and export of medical devices and laboratory instruments. It operates subsidiaries in Japan, Switzerland and the US. JCR is headquartered in Ashiya, Hyogo, Japan.

JCR Pharmaceuticals Co Ltd (4552) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11
NanoCarrier Enters into Agreement with JCR Pharma 12
JCR Pharma Plans to Form Joint Venture with MediPal 13
JCR Pharma Enters into Agreement with Eisai 14
Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15
Licensing Agreements 16
JCR Pharma Enters into Licensing Agreement with Mesoblast 16
Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17
Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18
Acquisition 19
MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19
JCR Pharmaceuticals Co Ltd – Key Competitors 20
JCR Pharmaceuticals Co Ltd – Key Employees 21
JCR Pharmaceuticals Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Strategy And Business Planning 24
Apr 26, 2018: JCR Announces Construction of the Second Clinical Trial Material Manufacturing Center 24
Product News 25
10/26/2017: JCR to Initiate Development of JR-171, a New Drug Candidate for Hurler Syndrome Using J-Brain Cargo 25
09/14/2018: JCR to initiate development of a new drug candidate for sanfilippo syndrome Type A using J-Brain Cargo 26
03/31/2017: JCR Announces First Patient Dosed in Phase 1/2 Clinical Trial of JR-141 in Hunter Syndrome 27
02/17/2017: JCR Announces Data Presentation on the Efficacy of BBB-Penetrating IDS on CNS in MPS II Mouse Model at the 13th Annual WORLDSymposium 2017 28
Clinical Trials 29
Jan 19, 2017: JCR announces completion of PMDA review of clinical trial plan for JR-141 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JCR Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Plasticell Enters Into Licensing Agreement With JCR Pharma For CombiCult 11
NanoCarrier Enters into Agreement with JCR Pharma 12
JCR Pharma Plans to Form Joint Venture with MediPal 13
JCR Pharma Enters into Agreement with Eisai 14
Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 15
JCR Pharma Enters into Licensing Agreement with Mesoblast 16
Sumitomo Dainippon Pharma Enters into Licensing Agreement with JCR Pharma 17
Teijin Enters into Licensing Agreement with JCR Pharma for JTR-161 18
MediPal Plans to Acquire 22% Stake in JCR Pharma from Glaxo Group for USD189.7 Million 19
JCR Pharmaceuticals Co Ltd, Key Competitors 20
JCR Pharmaceuticals Co Ltd, Key Employees 21
JCR Pharmaceuticals Co Ltd, Other Locations 22
JCR Pharmaceuticals Co Ltd, Subsidiaries 22

List of Figures
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JCR Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JCR Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dako AS-医療機器分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As:企業の戦略・SWOT・財務分析
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Faron Pharmaceuticals Oy (FARN)-製薬・医療分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • ALSO Holding AG:企業の戦略・SWOT・財務情報
    ALSO Holding AG - Strategy, SWOT and Corporate Finance Report Summary ALSO Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rafael Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), a subsidiary of IDT Corp is a healthcare products provider that offers therapeutics. The company develops drug therapies for the treatment of cancer. It provides altered energy metabolism directed platform for cancer cell energy metabolism …
  • Avivagen Inc (VIV):企業の財務・戦略的SWOT分析
    Summary Avivagen Inc (Avivagen), is a biotechnology company that provides drug development and animal healthcare products. It offers OxC-beta an active ingredient used to support the innate immune system and a healthy inflammatory condition of living beings. Avivagen's oxidized carotenoids promote a …
  • Johnson & Johnson (JNJ)-医療機器分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • IP Group Plc (IPO):企業の財務・戦略的SWOT分析
    Summary IP Group Plc (IP Group) is a provider of venture capital, business building and support, networks and recruitment services. The company invests in companies, which comprise early stage to mature businesses from various sectors such as energy and renewables, medical equipment and supplies, ph …
  • Five Star Senior Living Inc (FVE):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Dowa Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PanAust Ltd:企業の戦略・SWOT・財務分析
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kansas Electric Power Cooperative Inc:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • QinetiQ Group plc:戦略・SWOT・企業財務分析
    QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shanghai Pharmaceutical Co Ltd (601607):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. The company carries out the research and development, manufacture and sale of pharmaceutical products for treating HER2 positive advanced breast cancer, systemic a …
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Imdex Ltd (IMD):企業の財務・戦略的SWOT分析
    Imdex Ltd (IMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Marathon Petroleum Corporation:企業の戦略・SWOT・財務情報
    Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kennametal Inc.:企業の戦略・SWOT・財務分析
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆